RY

163.37

+1.01%↑

TD

94.61

+1.43%↑

BMO

137.05

+1.25%↑

CM

96.22

+1.58%↑

BNS

70.1

+1.15%↑

RY

163.37

+1.01%↑

TD

94.61

+1.43%↑

BMO

137.05

+1.25%↑

CM

96.22

+1.58%↑

BNS

70.1

+1.15%↑

RY

163.37

+1.01%↑

TD

94.61

+1.43%↑

BMO

137.05

+1.25%↑

CM

96.22

+1.58%↑

BNS

70.1

+1.15%↑

RY

163.37

+1.01%↑

TD

94.61

+1.43%↑

BMO

137.05

+1.25%↑

CM

96.22

+1.58%↑

BNS

70.1

+1.15%↑

RY

163.37

+1.01%↑

TD

94.61

+1.43%↑

BMO

137.05

+1.25%↑

CM

96.22

+1.58%↑

BNS

70.1

+1.15%↑

Search

Cullen-Frost Bankers Inc

Abierto

SectorFinanzas

138.67 1.07

Resumen

Variación precio

24h

Actual

Mínimo

135.07

Máximo

139.38

Métricas clave

By Trading Economics

Ingresos

-8.1M

166M

Ventas

359K

746M

P/B

Media del Sector

13.641

54.484

BPA

2.56

Rentabilidad por dividendo

2.95

Margen de beneficios

22.288

Empleados

6,008

EBITDA

-10M

220M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

+9.62% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

2.95%

4.92%

Próximas Ganancias

30 abr 2026

Fecha Próximo Dividendo

12 jun 2026

Próxima Fecha de Ex Dividendo

29 may 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-217M

8.6B

Apertura anterior

137.6

Cierre anterior

138.67

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

171 / 441 Clasificación en Finance

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Cullen-Frost Bankers Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

31 mar 2026, 23:31 UTC

Acciones populares

Stocks to Watch: Nike, RH, NCino

31 mar 2026, 22:35 UTC

Ganancias

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

1 abr 2026, 00:00 UTC

Adquisiciones, fusiones, absorciones

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

31 mar 2026, 23:50 UTC

Adquisiciones, fusiones, absorciones

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

31 mar 2026, 23:43 UTC

Charlas de Mercado

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

31 mar 2026, 23:33 UTC

Charlas de Mercado
Noticias de Eventos Importantes

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

31 mar 2026, 23:21 UTC

Ganancias

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

31 mar 2026, 23:14 UTC

Charlas de Mercado
Ganancias

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

31 mar 2026, 23:12 UTC

Charlas de Mercado

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

31 mar 2026, 22:36 UTC

Ganancias

China Vanke 2025 Loss Widens >000002.SZ

31 mar 2026, 22:36 UTC

Ganancias

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

31 mar 2026, 22:36 UTC

Ganancias

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

31 mar 2026, 22:36 UTC

Ganancias

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

31 mar 2026, 22:36 UTC

Ganancias

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

31 mar 2026, 21:46 UTC

Adquisiciones, fusiones, absorciones

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

31 mar 2026, 21:36 UTC

Charlas de Mercado

West African Resources's Costs Higher Than Bull Expected -- Market Talk

31 mar 2026, 21:35 UTC

Ganancias

Nike Expects China Sales Down 20% in 4Q, CFO Says

31 mar 2026, 21:35 UTC

Ganancias

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

31 mar 2026, 21:35 UTC

Ganancias

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

31 mar 2026, 21:33 UTC

Adquisiciones, fusiones, absorciones

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

31 mar 2026, 21:33 UTC

Ganancias

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

31 mar 2026, 21:32 UTC

Ganancias

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

31 mar 2026, 21:28 UTC

Ganancias

Nike Expects to End 4Q With Elevated Inventory, CFO Says

31 mar 2026, 21:26 UTC

Ganancias

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

31 mar 2026, 21:25 UTC

Ganancias

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

31 mar 2026, 21:24 UTC

Charlas de Mercado
Ganancias

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

31 mar 2026, 21:22 UTC

Ganancias

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

31 mar 2026, 21:22 UTC

Ganancias

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

31 mar 2026, 21:21 UTC

Ganancias

Nike's Digital Channel Still Too Promotional, CFO Says

31 mar 2026, 21:20 UTC

Ganancias

Nike CEO: Converse Remains Important to Portfolio

Comparación entre iguales

Cambio de precio

Cullen-Frost Bankers Inc previsión

Precio Objetivo

By TipRanks

9.62% repunte

Estimación a 12 Meses

Media 150.27 USD  9.62%

Máximo 163 USD

Mínimo 125 USD

De acuerdo con 12 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Cullen-Frost Bankers Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

12 ratings

5

Comprar

5

Mantener

2

Vender

Puntuación técnica

By Trading Central

116.35 / 125.23Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Weak Bullish Evidence

Sentimiento

By Acuity

171 / 441 Clasificación en Finanzas

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Cullen-Frost Bankers Inc

Cullen/Frost Bankers, Inc. operates as the bank holding company for Frost Bank that provides commercial and consumer banking services in Texas. The company offers commercial banking services to corporations, including financing for industrial and commercial properties, interim construction related to industrial and commercial properties, equipment, inventories and accounts receivables, and acquisitions; and treasury management services, as well as originates commercial leasing services. It also provides consumer banking services, such as checking accounts, savings programs, automated-teller machines (ATMs), overdraft facilities, installment and real estate loans, first mortgage loans, home equity loans and lines of credit, drive-in and night deposit services, safe deposit facilities, and brokerage services. In addition, the company offers international banking services comprising deposits, loans, letters of credit, foreign collections, funds transmitting, and foreign exchange services; correspondent banking activities, including check clearing, transfer of funds, fixed income security services, and securities custody and clearance services. Further, it offers trust, investment, agency, and custodial services for individual and corporate clients; capital market services that include sales and trading, new issue underwriting, money market trading, advisory, and securities safekeeping and clearance; and support for international business activities, including foreign exchange, letters of credit, export-import financing, and other related activities. Additionally, the company offers insurance and securities brokerage services; holding of securities for investment purposes; and investment management services for mutual funds, institutions, and individuals. It serves energy, manufacturing, services, construction, retail, telecommunications, healthcare, military, and transportation industries. The company was founded in 1868 and is headquartered in San Antonio, Texas.
help-icon Live chat